Fact CheckerSign in

NCT07493434Enrolling by invitation

Evaluation of Pain Thresholds in Migraine Patients After Inhalation of Essential Oils: a Randomized Clinical Trial

Source: ClinicalTrials.gov · Last updated 25 Mar 2026

Brief summary (registry, in English)

This study will test whether inhaling essential oils can change how sensitive people with migraine are to pressure pain. Participants will be allocated to inhale lavender, peppermint, a combination of both, or a control solution (distilled water with coconut oil). Each group will have 50 participants. The inhalation will last 15 minutes and will happen only once. Before and after the inhalation, we will measure how much pressure on certain areas of the head.

Status (registry)
Enrolling by invitation
Study type
Interventional
Enrollment
200 (estimated)
First submitted
14 Mar 2026
Start date
13 Mar 2025
Primary completion date
Mar 2027
Lead sponsor
University of Sao Paulo
Diseases
Migraine
NCT number
NCT07493434

What you commit to

  • Study type: Interventional
  • Planned participants: 200
  • From 13 Mar 2025 to the primary completion date, Mar 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Severe acute circulatory disorders
  • Diabetes melitus
  • Uncontrolled arterial hypertension
  • Known allergy or hypersensitivity to essential oils or their components

Other

  • Fribromyagia
  • Anosmia or hyposmia
  • Pregnancy or breastfeeding

Who the study is looking for

  • Adults aged 18-65 years
  • Diagnosis of episodic or chronic migraine according to the Internactional Classification of Headache Disorders (ICDH-3)
  • History of migraine for at least 1 year
  • Ability to understand and provide informed consent
  • Participants currently using or not using migraine preventive medication

Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Intitute of Psychiatry- Hospital das Clínicas, University of São Paulo
Coordinator of this site? Confirm its status
São PauloBrazilUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.